Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences - PubMed (original) (raw)
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences
Edward V Loftus Jr. Gastroenterology. 2004 May.
Abstract
Although the incidence and prevalence of ulcerative colitis and Crohn's disease are beginning to stabilize in high-incidence areas such as northern Europe and North America, they continue to rise in low-incidence areas such as southern Europe, Asia, and much of the developing world. As many as 1.4 million persons in the United States and 2.2 million persons in Europe suffer from these diseases. Previously noted racial and ethnic differences seem to be narrowing. Differences in incidence across age, time, and geographic region suggest that environmental factors significantly modify the expression of Crohn's disease and ulcerative colitis. The strongest environmental factors identified are cigarette smoking and appendectomy. Whether other factors such as diet, oral contraceptives, perinatal/childhood infections, or atypical mycobacterial infections play a role in expression of inflammatory bowel disease remains unclear. Additional epidemiologic studies to define better the burden of illness, explore the mechanism of association with environmental factors, and identify new risk factors are needed.
Similar articles
- Epidemiology of inflammatory bowel disease.
Whelan G. Whelan G. Med Clin North Am. 1990 Jan;74(1):1-12. doi: 10.1016/s0025-7125(16)30581-8. Med Clin North Am. 1990. PMID: 2404170 Review. - A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
Vcev A, Pezerovic D, Jovanovic Z, Nakic D, Vcev I, Majnarić L. Vcev A, et al. Wien Klin Wochenschr. 2015 May;127(9-10):345-54. doi: 10.1007/s00508-015-0741-7. Epub 2015 Mar 28. Wien Klin Wochenschr. 2015. PMID: 25821054 - [Changes in the epidemiology of inflammatory bowel diseases].
Lakatos L, Lakatos PL. Lakatos L, et al. Orv Hetil. 2007 Feb 4;148(5):223-8. doi: 10.1556/OH.2007.27906. Orv Hetil. 2007. PMID: 17344143 Review. Hungarian. - Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007.
Vahedi H, Merat S, Momtahen S, Olfati G, Kazzazi AS, Tabrizian T, Rashtak S, Khaleghnejad R, Khademi H, Malekzadeh F, Nasseri-Moghaddam S, Malekzadeh R. Vahedi H, et al. Arch Iran Med. 2009 Sep;12(5):454-60. Arch Iran Med. 2009. PMID: 19722766 - The Search for Causative Environmental Factors in Inflammatory Bowel Disease.
Rogler G, Zeitz J, Biedermann L. Rogler G, et al. Dig Dis. 2016;34 Suppl 1:48-55. doi: 10.1159/000447283. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548430
Cited by
- Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases.
Harris RA, Nagy-Szakal D, Pedersen N, Opekun A, Bronsky J, Munkholm P, Jespersgaard C, Andersen P, Melegh B, Ferry G, Jess T, Kellermayer R. Harris RA, et al. Inflamm Bowel Dis. 2012 Dec;18(12):2334-41. doi: 10.1002/ibd.22956. Epub 2012 Mar 29. Inflamm Bowel Dis. 2012. PMID: 22467598 Free PMC article. - Cancer immunotherapy in patients with preexisting autoimmune disorders.
Donia M, Pedersen M, Svane IM. Donia M, et al. Semin Immunopathol. 2017 Apr;39(3):333-337. doi: 10.1007/s00281-016-0595-8. Epub 2016 Oct 11. Semin Immunopathol. 2017. PMID: 27730287 Review. - Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reducing inflammation in inflammatory bowel diseases.
Holman J, Hurd M, Moses PL, Mawe GM, Zhang T, Ishaq SL, Li Y. Holman J, et al. J Nutr Biochem. 2023 Mar;113:109238. doi: 10.1016/j.jnutbio.2022.109238. Epub 2022 Nov 26. J Nutr Biochem. 2023. PMID: 36442719 Free PMC article. Review. - 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages.
Chen Y, Liu W, Sun T, Huang Y, Wang Y, Deb DK, Yoon D, Kong J, Thadhani R, Li YC. Chen Y, et al. J Immunol. 2013 Apr 1;190(7):3687-95. doi: 10.4049/jimmunol.1203273. Epub 2013 Feb 22. J Immunol. 2013. PMID: 23436936 Free PMC article. - Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
Kudelka MR, Stowell SR, Cummings RD, Neish AS. Kudelka MR, et al. Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):597-617. doi: 10.1038/s41575-020-0331-7. Epub 2020 Jul 24. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32710014 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials